13
Participants
Start Date
March 31, 2016
Primary Completion Date
May 31, 2021
Study Completion Date
May 31, 2021
Victoza® (liraglutide)
Daily subcutaneous injections with increasing doses up to 1.8 mg per day. Duration of treatment 6 months. Duration of follow-up 6 months.
Placebo
Daily subcutaneous injections with increasing doses up to 1.8 mg per day. Duration of treatment 6 months. Duration of follow-up 6 months.
University of Turku and Turku University Hospital, Turku
University of Tampere and Tampere University Hospital, Tampere
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents, Oulu
Lund University and Skåne University Hospital, Malmo
Oulu University Hospital
OTHER
Tampere University Hospital
OTHER
Turku University Hospital
OTHER_GOV
Skane University Hospital
OTHER
University of Oulu
OTHER